Predicting the Risk of nOdal disease with histological and Molecular features in Endometrial cancer: the prospective PROME trial
Objective To assess the role of histopathological and molecular features in predicting the
risk of nodal metastases in apparent early-stage endometrial cancer patients undergoing …
risk of nodal metastases in apparent early-stage endometrial cancer patients undergoing …
Predicting the Risk of nOdal disease with histological and Molecular features in Endometrial cancer: the prospective PROME trial
G Bogani, L Lalli, J Casarin, F Ghezzi… - … : official journal of the … - pubmed.ncbi.nlm.nih.gov
Objective To assess the role of histopathological and molecular features in predicting the
risk of nodal metastases in apparent early-stage endometrial cancer patients undergoing …
risk of nodal metastases in apparent early-stage endometrial cancer patients undergoing …
Predicting the Risk of nOdal disease with histological and Molecular features in Endometrial cancer: the prospective PROME trial.
G Bogani, L Lalli, J Casarin, F Ghezzi… - … : Official Journal of the …, 2024 - europepmc.org
Objective To assess the role of histopathological and molecular features in predicting the
risk of nodal metastases in apparent early-stage endometrial cancer patients undergoing …
risk of nodal metastases in apparent early-stage endometrial cancer patients undergoing …